Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft Versus Host Disease in Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Not applicableUnknownNCT01438385
What this trial is testing

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Who this might be right for
Ampullary CancerDuodenal CancerBile Duct Cancer+20 more
Weill Medical College of Cornell University 12,000
Not applicableStudy completedNCT03334968
What this trial is testing

Prolidase Enzyme Activity in Stroke Patients

Who this might be right for
Stroke, IschemicProlidase Deficiency
Bezmialem Vakif University 74
Testing effectiveness (Phase 2)Study completedNCT00397579
What this trial is testing

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesBlastic Plasmacytoid Dendritic Cell Neoplasm
University of Texas Southwestern Medical Center 11
Not applicableStudy completedNCT01138917
What this trial is testing

Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries

Who this might be right for
Burns
Avita Medical 101
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Not applicableStudy completedNCT01544959
What this trial is testing

Postoperative Analgesia Impact of Narcotic Free Anesthesia

Who this might be right for
Pain, PostoperativeBreast CancerPostoperative Nausea and Vomiting
Université de Sherbrooke 84
Not applicableStudy completedNCT03093805
What this trial is testing

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin

Who this might be right for
Graft Vs Host Disease
Children's Hospital Medical Center, Cincinnati 10
Not applicableStudy completedNCT05124197
What this trial is testing

Extended Prone Position Duration COVID-19-related ARDS: a Retrospective Study

Who this might be right for
Pressure UlcerRespiratory Distress Syndrome, AcuteHypoxemic Respiratory Failure+1 more
Hôpital Louis Mourier 81
Not applicableStudy completedNCT03070925
What this trial is testing

Prospective PuraPly™ AM Case Series Study

Who this might be right for
Pressure UlcersVenous UlcersDiabetic Ulcers+2 more
Organogenesis 43
Testing effectiveness (Phase 2)Study completedNCT03782792
What this trial is testing

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 53
Large-scale testing (Phase 3)Study completedNCT00292981
What this trial is testing

C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Who this might be right for
Hereditary Angioedema
CSL Behring 57
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)Study completedNCT02111564
What this trial is testing

Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

Who this might be right for
Heart FailureRespiratory InsufficiencyStroke Acute+2 more
Janssen Research & Development, LLC 12,024
Not applicableStudy completedNCT00343863
What this trial is testing

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Who this might be right for
Male Breast CancerNausea and VomitingStage I Breast Cancer+2 more
University of Washington 41
Post-approval studies (Phase 4)WithdrawnNCT02281799
What this trial is testing

Thiopurine Induced Pancreatitis in IBD Patients

Who this might be right for
PancreatitisInflammatory Bowel Diseases
Shaare Zedek Medical Center
Large-scale testing (Phase 3)Study completedNCT02565680
What this trial is testing

Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency

Who this might be right for
Acute Urticaria
University Hospital, Toulouse 100
Not applicableStudy completedNCT05615883
What this trial is testing

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients

Who this might be right for
Melanoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 16
Large-scale testing (Phase 3)Study completedNCT04206605
What this trial is testing

Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Who this might be right for
Angioedema
Takeda 77
Next Page